Clinical Trials · NCT02554279

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Name: MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Gonadorelin

Phase: Phase 4
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 620
Start date: Aug 2015
Locations: 35 sites, United States
Primary endpoint: Ongoing Pregnancy Rate

View Gonadorelin compound reference